20 Oct 2020 Bone Therapeutics reaches 50% treated patients in ongoing JTA-004 Phase III pivotal knee osteoarthritis study Member news
16 Oct 2020 Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients Member news
14 Oct 2020 Bone Therapeutics’ allogeneic cell therapy product, ALLOB, shows 90% fusion rate at 24 months in Phase IIa study in lumbar spinal fusion Member news
13 Oct 2020 Phase 2B/3 Trial shows efficacy of Filgotinib for the induction and maintenance of remission in moderately and severely active Ulcerative Colitis Member news
30 Sep 2020 Galapagos announces first dosing with Toledo compound GLPG3970 in psoriasis trial Member news
29 Sep 2020 Celyad Oncology announces clinical trial collaboration to evaluate CYAD-101 with KEYTRUDA® (pembrolizumab) in patients with Microsatellite Stable mCRC Member news
24 Sep 2020 Johnson & Johnson initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 vaccine candidate Member news
22 Sep 2020 Camel-IDS enters next stage with name change to PRECIRIX® and IND approval for CAM-H2 Phase I/II study Member news
11 Sep 2020 Primary endpoint achieved with ziritaxestat in NOVESA trial in systemic sclerosis patients Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
